Congenital Heart Disease (CHD), known locally in Indonesia as Penyakit Jantung Bawaan (PJB), remains one of the most significant challenges in pediatric medicine, representing a complex array of structural abnormalities that develop before a child is even born. While the precise etiology of these cardiac malformations often remains elusive to medical science, healthcare experts are increasingly focusing on identifiable and preventable risk factors that occur during pregnancy. According to dr. Rizky Adriansyah, MKed, a pediatric specialist and Chairman of the Cardiology Coordination Staff Unit of the Indonesian Pediatric Society (IDAI), while a direct cause-and-effect relationship is difficult to establish in every individual case, there is a clear correlation between certain maternal conditions and the incidence of CHD in newborns.
During a recent health webinar, dr. Rizky emphasized that although the exact trigger for the malformation of the heart during fetal development is often unknown, three specific risk factors have dominated recent medical literature and clinical discussions: maternal infection with the rubella virus, a deficiency in folic acid intake, and the consumption of certain medications, particularly anti-seizure drugs, during pregnancy. These factors can disrupt the delicate process of organogenesis, the period when the internal organs, including the heart, are being formed in the womb.
The Triad of Modern Risk Factors in Fetal Cardiac Development
The first major risk factor, the rubella virus, is a well-documented teratogen—an agent that can cause birth defects. When a pregnant woman contracts rubella, particularly during the first trimester, the virus can cross the placental barrier and interfere with the development of the fetal heart, eyes, and hearing. This has led to a national push in Indonesia for rubella vaccinations before women reach childbearing age. If a mother is immune to rubella, one of the most significant environmental risks for CHD is effectively neutralized.
Secondly, the role of folic acid (Vitamin B9) has gained substantial attention in maternal health protocols. Folic acid is essential for DNA synthesis and repair, and its deficiency has been linked not only to neural tube defects but also to a higher prevalence of heart defects. Medical experts suggest that folic acid supplementation should ideally begin before conception to ensure that the nutrient is present in sufficient quantities during the earliest weeks of pregnancy when the heart begins its rudimentary formation.
The third major factor involves the use of specific pharmaceutical interventions. Women who suffer from chronic conditions such as epilepsy may require anti-seizure medications. However, certain classes of these drugs are known to carry risks for the developing fetus. Dr. Rizky noted that while these medications are often necessary for the mother’s health, they must be managed under strict medical supervision to balance the mother’s neurological stability with the baby’s cardiac health.
Beyond these primary three, lifestyle choices such as smoking and alcohol consumption have long been categorized as risk factors. However, clinical data in Indonesia presents a nuanced picture; many cases of CHD occur in children whose mothers did not smoke or drink alcohol, suggesting that environmental factors, genetics, and nutritional deficiencies play a more significant role in the local context than previously assumed.
Statistical Overview and the Indonesian Context
The impact of Congenital Heart Disease on Indonesia’s public health landscape is profound. Data from 2017 indicates that CHD is the second leading cause of neonatal mortality in the country, accounting for approximately 17 percent of deaths in the first month of life, surpassed only by complications related to prematurity. This statistic underscores the urgency of improving both prenatal care and postnatal diagnostic capabilities.
Global data from the World Health Organization (WHO) reinforces the scale of this issue, stating that approximately one in every 100 newborns suffers from some form of CHD. Of these cases, roughly 25 percent are classified as "critical" CHD. Critical CHD cases are those that require surgical intervention or catheter-based procedures within the first year—and often the first days—of life to ensure survival. In Indonesia, this translates to a rate of two to four critical CHD cases for every 1,000 live births.
Despite the high incidence rate, the treatment gap in Indonesia remains a significant hurdle. Dr. Rizky pointed out that less than 50 percent of CHD cases in the country are currently being handled or treated effectively. This disparity is attributed to a multifaceted set of challenges, including limited geographical access to specialized cardiac centers, a shortage of advanced diagnostic equipment in rural areas, a lack of specialized pediatric cardiologists and surgeons, and a general lack of public awareness regarding the symptoms of heart defects in infants.
Challenges in Diagnosis and the Role of Modern Screening
One of the primary obstacles to improving survival rates for children with CHD in Indonesia is the delay in diagnosis. Many infants are discharged from birth facilities appearing healthy, only to develop life-threatening symptoms days or weeks later. To combat this, the medical community is advocating for the widespread adoption of simple, cost-effective screening methods.
Pulse oximetry has emerged as a vital tool in this effort. By measuring the oxygen saturation in a newborn’s blood—specifically by comparing readings from the right hand and either foot—healthcare providers can detect signs of critical CHD that might not be visible to the naked eye. This test is non-invasive, fast, and relatively inexpensive, making it an ideal screening tool for the diverse and often resource-limited landscape of the Indonesian archipelago.
In addition to oximetry, the traditional stethoscope remains a fundamental tool. The presence of a "murmur"—an unusual sound heard during a heartbeat—can be an early indicator of structural heart issues. If a murmur is detected, it should immediately trigger a referral for an echocardiography, an ultrasound of the heart that provides a detailed image of the cardiac structure and blood flow.
Clinical symptoms of CHD in infants can be subtle but are critical for parents and primary caregivers to recognize. These include:
- Slow Weight Gain: Infants with CHD often tire easily during feeding, leading to inadequate caloric intake and "failure to thrive."
- Cyanosis: A bluish tint to the skin, lips, or fingernails, indicating low oxygen levels in the blood.
- Rapid Breathing: The heart must work harder to pump blood, often causing the infant to breathe faster or with more effort.
- Poor Feeding: The baby may sweat during feeding or become exhausted after only a few minutes.
Critical cases often manifest very early, typically within the first 24 to 48 hours or the first week of life, making the immediate postnatal period the most critical window for intervention.
The Role of Education and Healthcare Infrastructure
To address the educational gap, the IDAI and other health organizations are utilizing digital platforms to reach both parents and healthcare professionals. Dr. Rizky highlighted the YouTube channel "Sehatkan Jantung Anak Indonesia" as a resource for education on cardiac screening. The goal is to empower frontline health workers, such as midwives in community health centers (Puskesmas), to perform basic cardiac screenings.
Midwives play a crucial role in the Indonesian healthcare system, often being the first point of contact for pregnant women and newborns in rural areas. If a midwife can perform a five-minute oximetry check or recognize the signs of a heart murmur, the speed of referral to a specialist can be significantly increased. Early detection is not just a medical necessity; it is a logistical one. In a country where the few specialized cardiac centers are concentrated in major cities like Jakarta, Surabaya, and Bandung, early diagnosis allows families the time needed to arrange for travel and treatment before the infant’s condition becomes unstable.
Analysis of Implications and Future Outlook
The persistence of high CHD mortality rates in Indonesia has broader implications for the nation’s human capital and economic development. When a significant portion of neonatal deaths is caused by a treatable or manageable condition, it places a strain on the healthcare system and results in a loss of potential for the next generation. Furthermore, the high cost of cardiac surgery and long-term care for children with untreated CHD can push families into financial instability.
The Indonesian government, through the Ministry of Health, has been working to expand the capacity of regional hospitals to handle cardiac cases. However, the bottleneck remains the specialized human resources. Training a pediatric cardiac surgeon or a pediatric cardiologist takes years of intensive study and practice. Therefore, the short-term strategy must focus heavily on prevention and early detection.
From a policy perspective, the integration of CHD screening into the standard newborn care package is essential. While the BPJS (National Health Insurance) covers many treatments, the standardization of screening protocols across all provinces would ensure that a child born in a remote village in Papua has the same chance of survival as a child born in a private hospital in Jakarta.
The preventive measures discussed—rubella vaccination and nutritional supplementation—are also matters of public health policy. Strengthening the national immunization program and ensuring that prenatal vitamins are accessible to all pregnant women, regardless of their socio-economic status, are foundational steps in reducing the national burden of CHD.
In conclusion, while the path to eradicating Congenital Heart Disease is obstructed by the unknown nature of its causes, the path to reducing its impact is clear. Through a combination of maternal education, rigorous prenatal care, universal newborn screening, and the expansion of specialized medical infrastructure, Indonesia can move toward a future where every child born with a heart defect is given a fighting chance at a healthy life. The message from the medical community is one of urgency and vigilance: the health of a child’s heart begins long before their first breath, and the window for life-saving intervention is often measured in hours, not days.
